Darla Graff

Darla Graff

Akerman LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Post-Myriad Strategies for Claiming Biotech Inventions in the United States

The United States Supreme Court recently ruled that genes or other naturally-occurring pieces of DNA are patent ineligible subject matter in Association for Molecular Pathology, et al. v. Myriad Genetics, Inc., et al. No....more

7/16/2013 - AMP v Myriad Biotechnology DNA Inventions Myriad Patent-Eligible Subject Matter Patents SCOTUS USPTO

1 Results
|
View per page
Page: of 1